Clinical Trial Translation Services

What are clinical trial translation services and why do they matter?

Clinical trial translation services convert protocols, informed consent forms, investigator brochures, case report forms and regulatory submissions into 150+ languages under an ISO 17100 workflow, so multi-country trials meet MHRA, EU CTR and FDA language rules without compromising patient safety.

Which clinical trial documents do we translate?

We translate 9 clinical trial document types: protocols, investigator brochures, informed consent forms, case report forms, CIOMS reports, ethics submissions, patient diaries, SAE narratives and lay summaries — plus recruitment materials and Clinical Outcome Assessments.

How much do clinical trial translation services cost in the UK?

Clinical trial translation services in the UK cost £0.10–£0.20 per word depending on language pair, subject complexity and validation tier, with short personal certificates quoted from £25 per document and same-day or weekend delivery adding a 30–50% surcharge.

How long does clinical trial translation take?

Standard clinical trial translation takes 2–3 working days per document under our ISO 17100 workflow; multi-document regulatory dossiers, protocols over 50 pages and full linguistic validation projects are scoped and quoted individually.

What regulatory standards and ISO 17100 requirements apply to clinical trial translation?

Clinical trial translation is governed by ISO 17100 for process, UK GDPR for data, MHRA and the EU Clinical Trials Regulation (EU 536/2014) for submissions, and FDA 21 CFR 50.20 for informed consent — every job we deliver is checked by a second linguist under ISO 17100.

What is our clinical trial translation process and how do we ensure quality?

Our clinical trial translation process runs seven structured stages — kick-off and glossary build, translation by a subject-matter linguist, second-linguist revision under ISO 17100, back translation and reconciliation where required, in-country review, DTP and signed delivery — each stage logged for the audit trail.

UK sponsors, contract research organisations and academic research teams commissioning multi-country studies need certified translation of protocols, informed consent forms and regulatory dossiers under an auditable ISO 17100 workflow. This page sets out our fixed document scope, pricing, turnaround and MHRA/EU CTR alignment for London-based sponsors and their global sites.

What are clinical trial translation services and why do they matter?

Clinical trial translation services convert protocols, informed consent forms, investigator brochures, case report forms and regulatory submissions into 150+ languages under an ISO 17100 workflow, so multi-country trials meet MHRA, EU CTR and FDA language rules without compromising patient safety. Clinical trial translation matters because a single mistranslated risk clause can invalidate consent, delay ethics approval or void trial data. The service spans the full trial lifecycle — from first-in-human protocols through to post-study lay summaries — and is delivered by translators who hold recognised qualifications in life sciences or medicine, with every project passing a mandatory second-linguist revision before sign-off.

Three attributes define the service:

• Scope — 9 clinical trial document types, plus recruitment materials and Clinical Outcome Assessments.
• Quality framework — ISO 17100 process with second-linguist QC and a signed certificate of accuracy at no extra cost.
• Commercial anchor — £0.10–£0.20 per word, 2–3 working days, 30–50% surcharge for same-day or weekend delivery.

Our network of medical and clinical translators and linguistic validation specialists is large enough to support simultaneous multi-language releases across complex global programmes, which means sponsors do not need to manage multiple vendors for different language pairs. Translation memory tools and client-specific glossaries are applied from kick-off, so consistency is built in rather than retrofitted at review — reducing late-stage reconciliation costs and protecting the scientific integrity of endpoints across every target language.

Why does accurate clinical trial translation matter for patient safety and trial validity?

Accurate clinical trial translation preserves the informed consent process, protects patient safety and defends trial validity. A poor translation of an ICF can invalidate consent, delay ethics approval and put a whole cohort's data at risk. Clinical trials fail when trial participants misunderstand risk language, dosing schedules or withdrawal rights in their native language — and regulators including the MHRA, EMA and FDA treat inadequate consent-language translation as a serious protocol deviation. Beyond consent, endpoint data collected via poorly translated patient diaries or PRO instruments is at risk of disqualification during regulatory review. Translation preserves the scientific integrity of endpoints across every target language and is therefore a patient-safety issue, not merely an administrative one.

Who buys clinical trial translation services in the UK?

UK buyers of clinical trial translation services include 6 groups:

Which clinical trial documents do you translate?

We translate 9 clinical trial document types: protocols, investigator brochures, informed consent forms, case report forms, CIOMS reports, ethics submissions, patient diaries, SAE narratives and lay summaries — plus recruitment materials and Clinical Outcome Assessments. Each document maps to a defined MHRA or EU CTR submission stage. Our Medical Translation service houses the wider clinical document catalogue, including discharge summaries and hospital records.

Document type	Audience	Submission stage
Protocol and amendments	Regulator, ethics, site	MHRA CTA, EU CTIS Part I
Investigator brochure	Regulator, investigator	MHRA CTA, EU CTIS Part I
Informed consent form	Patient	Ethics, EU CTIS Part II
Case report form	Site	Trial conduct
CIOMS report	Regulator	Safety reporting
Ethics submission pack	REC / IRB	Ethics approval
Patient diary	Patient	Trial conduct
SAE narrative	Regulator, DSMB	Pharmacovigilance
Lay summary	Public	End-of-trial disclosure

What sponsor-facing regulatory documents do you handle?

Sponsor-facing regulatory documents include the trial protocol, protocol amendments, investigator brochure, IMPD sections, CIOMS reports, SAE narratives and clinical study reports submitted to the MHRA and EU CTIS. These clinical trial documents feed the CTA dossier and every subsequent variation. Our medical translators work from the source language into the regulator's required language with locked MedDRA terminology.

What patient-facing trial documents do you translate?

Patient-facing trial documents translated include:

Each translated document is written at a lay reading level and culturally adapted for the target market.

What site-facing and Clinical Outcome Assessment materials do you localise?

Site-facing materials include case report forms, CRF completion guidelines, site training decks, pharmacy manuals and Clinical Outcome Assessments (COAs), ePRO screens and eCOA scripts requiring full linguistic validation and cognitive debriefing. Trial teams at investigator sites use the localised training decks to align data capture across languages. Medical device manufacturers running MDR investigations also require translated IFUs alongside the CIP — covered in our Technical Translation service.

How much do clinical trial translation services cost in the UK?

Clinical trial translation services in the UK cost £0.10–£0.20 per word depending on language pair, subject complexity and validation tier. Short personal certificates are quoted from £25 per document. Same-day and weekend delivery add a 30–50% surcharge on SAE narratives and urgent amendments.

Service tier	Price	Turnaround	Includes
Forward translation only	£0.10–£0.14 per word	2–3 working days	ISO 17100 second-linguist QC, certificate of accuracy
Forward + back translation + reconciliation	£0.16–£0.20 per word	4–7 working days	Independent back translation, reconciliation report
Full linguistic validation	Quoted per project	4–8 weeks	Dual forward, back translation, cognitive debriefing, harmonisation
Same-day / weekend SAE narrative	+30–50% surcharge	Same day	Priority linguist and reviewer allocation

What drives the price of a clinical trial translation?

Four factors drive clinical trial translation price:

1. Language pair rarity — small-population regulator languages carry a higher rate.
2. Subject-matter complexity — oncology, cell and gene therapy content sits at the top of the £0.10–£0.20 range.
3. Document length beyond 250 words — short documents are priced per document.
4. Urgency — same-day or weekend delivery adds a 30–50% surcharge.

Is VAT charged on clinical trial translation for UK CROs?

UK VAT applies to translation services supplied to UK-established clients. Overseas sponsors invoiced outside the UK are generally treated under place-of-supply rules. Final treatment depends on the client's status and is confirmed on quotation.

Get a quote

How long does clinical trial translation take?

Standard clinical trial translation takes 2–3 working days per document under our ISO 17100 workflow. Multi-document regulatory dossiers, protocols over 50 pages and full linguistic validation projects are scoped and quoted individually. Turnaround assumes a clean source file; documents supplied in scanned or non-editable formats may require additional preparation time, which we flag before the project starts.

Several factors influence how quickly a project can be completed:

• Document type — a short SAE narrative is typically returned within one working day; a full investigator brochure or integrated clinical study report takes longer and is quoted individually.
• Language pair — high-frequency pairs such as French, German and Spanish are resourced immediately; rare or low-resource language pairs may require an additional scoping day to confirm reviewer availability.
• Translation memory depth — amendment cycles are materially shorter where translation memory has been built during the parent study, because previously approved segments are reused rather than retranslated from scratch.
• Urgency — same-day and weekend delivery is available for SAE narratives and urgent amendments at a 30–50% surcharge, with the cost agreed before work begins.

We provide a confirmed turnaround commitment — not an estimate — at the point of quote, so project managers can align translation milestones with ethics board submission windows and regulatory deadlines. For rolling programmes, we offer a schedule-of-rates agreement that locks both price and turnaround for the duration of the study.

What regulatory standards and ISO 17100 requirements apply to clinical trial translation?

Clinical trial translation is governed by ISO 17100 for process, UK GDPR for data, MHRA and the EU Clinical Trials Regulation (EU 536/2014) for submissions, and FDA 21 CFR 50.20 for informed consent — every job we deliver is checked by a second linguist under ISO 17100. ISO 9001 quality management often sits alongside ISO 17100 in clinical translation providers.

How do forward translation, back translation and reconciliation work?

Forward translation produces the target-language draft. Back translation converts it independently back to English by a linguist blind to the source. Reconciliation compares source and back-translated versions to flag semantic drift. This loop is required by most IRBs for informed consent forms and Clinical Outcome Assessments.

When is full linguistic validation and cognitive debriefing required?

Full linguistic validation with cognitive debriefing is required for Patient-Reported Outcome instruments, ePRO screens and Clinical Outcome Assessments. FDA, EMA and instrument developers demand harmonised, patient-tested wording across every target language before the instrument is fielded.

What are the 5 steps of linguistic validation for a PRO instrument?

1. Dual forward translation by two independent linguists.
2. Reconciliation of the two forward versions.
3. Back translation and comparison to source.
4. Cognitive debriefing with 5–8 patients per language.
5. Harmonisation across languages and final proofreading.

How do you manage terminology, translation memory and amendment control?

We manage terminology through 3 controls:

Translation memory reduces cost on repeated segments across ICFs, CRFs and site training decks.

How do clinical trial translation services support patient recruitment and informed consent?

Clinical trial translation services support patient recruitment and informed consent by producing readable, culturally adapted ICFs, assent forms, recruitment ads, screening scripts and study websites in the participant's native language — protecting consent validity and widening the recruitable population. Recruitment translation preserves the scientific claim while re-writing tone for the local market.

What technology do you use for clinical trial translation, including AI and machine translation?

Our translation technology stack combines translation memory, sponsor-approved glossaries, a secure CAT-tool environment and controlled machine translation with human post-editing. Machine translation is used for internal comprehension and volume safety data. It is never used unsupervised on patient-facing or regulator-facing content. Efficient translation workflows keep amendment turnaround short across long trials.

Human clinical translation vs machine translation: which do UK regulators accept?

UK regulators expect certified human translation for patient-facing and regulator-facing clinical trial documents. Raw machine translation is not accepted for ICFs, protocols or CSRs. Machine translation with human post-editing may be used for internal drafts and safety-data triage.

Content type	Human certified translation	MT + human post-editing	Raw MT
Informed consent form	Required	Not accepted	Not accepted
Protocol / CSR	Required	Not accepted	Not accepted
Internal safety triage	Optional	Accepted	Internal only
PRO / COA	Required (validated)	Not accepted	Not accepted

How do you handle sensitive trial data, confidentiality and information security?

We handle sensitive trial data under UK GDPR with NDA-bound linguists, ISO 17100 project controls, encrypted file transfer, role-based access, pseudonymisation of SAE narratives and CRFs, and secure UK-hosted project storage with a full audit trail. Every translator and reviewer who accesses trial documentation signs a project-specific confidentiality agreement before work begins, and access is restricted strictly to the personnel assigned to that project. No trial data is stored on personal devices or processed through unsecured consumer-grade tools.

Our technology environment is built around security as a baseline rather than an add-on. Secure, ISO 27001-aligned technologies underpin our translation management platform, meaning file transfer, translation memory storage and terminology databases are all protected by encryption at rest and in transit. Translation memory and glossary data are held in client-specific, isolated repositories — your study terminology is never co-mingled with another sponsor's data.

For SAE narratives and other highly sensitive patient-level documents, we apply pseudonymisation at the point of file preparation, replacing identifiable patient references with coded identifiers before the file is distributed to the translation team. The decoded master key is held solely by the project manager and is never shared with external linguists. Chief risk officers and vendor qualification teams reviewing our security posture receive a data-flow map, a sub-processor list and details of our technical and organisational measures on request. Quality control and data control run in parallel across every project, so no document reaches delivery without both a linguistic sign-off and a security-compliance check.

Which languages do you cover for clinical trial translation?

We cover 150+ languages for clinical trial translation, including every EU official language plus Arabic, Polish, Romanian, Urdu, Punjabi, Bengali, Mandarin, Cantonese, Portuguese, Tigrinya and Welsh. This breadth means a single vendor relationship supports pan-European CTIS submissions, MHRA requirements for patient-facing documents in the local language of each participating UK region, and rest-of-world sites in one co-ordinated workflow. Interpreting services are available through partnered linguists for investigator meetings, ethics hearings and patient visits.

Our clinical translator network spans over 2,500 medical and clinical translation specialists worldwide, each vetted for subject-matter qualifications in addition to linguistic competence. This depth of resource means that even high-volume, multi-language simultaneous releases — common at Phase III when multiple Member States are onboarded at once — are delivered without bottlenecks. Language pairs are matched not just on fluency but on therapeutic area: an oncology protocol is not assigned to a translator whose primary background is cardiology.

How do you scope rare-language pairs and small-population regulator languages?

Rare-language pairs and small-population regulator languages are scoped by pairing a domain-qualified translator with an in-country reviewer who holds verifiable credentials in the relevant therapeutic area. Turnaround extends where the reviewer pool is limited, and we communicate this clearly at feasibility stage. Feasibility is confirmed before commercial commitment, so global clinical research programmes are not blocked at the last participating country. Where an in-country review cannot be completed within the required window, we propose an alternative quality assurance step — such as a back-translation review or an independent expert check — and document the rationale in the project file for regulatory transparency.

How do I choose a reliable clinical trial translation service provider?

Choose a clinical trial translation partner on 6 evidence points: ISO 17100 certification, specialist clinical linguists, second-linguist QC, documented linguistic validation capability, UK GDPR-aligned data handling, and a published pricing and turnaround anchor — not marketing claims. A structured translation vendor gives sponsors an auditable trail, not a black box.

What questions should sponsors ask a clinical trial translation partner?

Sponsors should ask 7 questions:

1. Are your linguists clinical specialists in the relevant therapeutic area?
2. Do you hold ISO 17100 certification?
3. Can you provide back translation and reconciliation?
4. Do you offer full linguistic validation for PROs and COAs?
5. How do you protect UK GDPR data across the translation process?
6. What is your standard turnaround?
7. What is your price per word, and what is included?

Our London office at Suite 544, Unit B, 63-66 Hatton Garden, London EC1N 8LE covers the City, Canary Wharf, Harley Street and NHS London trusts, with courier hardcopy for regulator submissions and digital delivery to CRO sites in Manchester, Birmingham and Edinburgh. Call +44 20 4569 1419, Monday to Saturday, 9:00–18:00.

What are the common challenges and risks in clinical trial translation?

Common clinical trial translation risks include mistranslated informed consent language, drift between protocol amendments and site materials, inconsistent MedDRA terminology, missed ethics deadlines, and unvalidated PRO instruments — each mitigated by ISO 17100 QC, translation memory and version-controlled translation solutions. Poor translation of a single risk clause has voided consent in past studies, and regulators treat inadequate consent-language as a serious protocol deviation that can trigger site suspension or data disqualification.

Amendment drift is among the most insidious risks in long-running studies. When a protocol amendment is issued mid-study, every downstream document — the ICF, patient diary, site instructions and ethics cover letter — must be updated consistently and simultaneously. Clinical trial translations drift when amendments are handled without reference to the approved translation memory from the parent protocol, which is why we lock terminology and memory from kick-off and apply it to every subsequent change. This approach is reinforced by client-specific glossaries that are maintained and versioned throughout the study, ensuring that MedDRA terms, study-specific endpoints and product names are rendered identically across all documents and all languages.

Regulatory complexity adds a further layer of risk. EU Clinical Trials Regulation 536/2014 requires patient-facing documents to be translated into the official language of each Member State where the trial runs and submitted via CTIS — a requirement that demands precise version control across potentially 27 language variants of the same document. FDA regulations governing informed consent require that the language used is understandable to the subject, which means readability review is a necessary companion to translation accuracy. Our process addresses both dimensions: linguistic accuracy under ISO 17100 and readability review for patient-facing documents, with the output documented in a signed certificate of accuracy that accompanies every regulatory submission.

Linguistic validation of Clinical Outcome Assessments and Patient-Reported Outcomes presents its own structured challenge. The process — forward translation, back translation, reconciliation and cognitive debriefing — is not optional for validated instruments; it is a regulatory expectation. Skipping or abbreviating any stage risks invalidating the endpoint data collected by that instrument across the entire study population. Our Certified Translation Services page sets out the certificate of accuracy that accompanies every regulatory submission.

Clinical trial translation services cost £0.10–£0.20 per word depending on language pair and subject complexity. Short documents are priced per document from £25. Same-day and weekend delivery add a 30–50% surcharge.

Frequently asked questions

How much do professional translation services typically cost?

Professional translation services in the UK typically cost £0.10–£0.20 per word for certified work, depending on the language pair and subject matter. Single personal documents such as birth certificates, marriage certificates, diplomas or passports are often quoted at a fixed rate starting from £25 per document. Large technical, legal or regulatory projects — such as clinical trial dossiers — are quoted individually, as volume, complexity and turnaround requirements all affect the final price. Standard turnaround is 2–3 working days.

Who can certify a translation in the UK?

In the UK, a certified translation must be produced or overseen by a qualified, professional translator who signs a certificate of accuracy confirming the translation is complete and correct. There is no single statutory licensing body, but accepted practice requires the translator to be competent in the subject area and to provide a signed statement on headed paper alongside the translation. Providers following an ISO 17100 process — which mandates a second linguist check — are widely regarded as meeting the highest professional standard for regulatory, legal and clinical submissions.

How much does a certified translation cost in the UK?

Certified translation in the UK costs £0.10–£0.20 per word, varying by language pair and technical complexity. Single personal documents — such as birth certificates, marriage certificates, passports or diplomas — start from £25 per document on a fixed-price basis. A signed certificate of accuracy is included in every certified translation at no extra cost. Same-day or weekend delivery is available at a 30–50% surcharge; standard turnaround is 2–3 working days. Large clinical, legal or regulatory projects are quoted individually.

Can anyone do a certified translation?

No — a certified translation must be carried out by a suitably qualified professional translator, not by just anyone bilingual. The translator must sign a certificate of accuracy confirming the translation is a true and complete representation of the source document, and they must be competent in the relevant subject area (e.g. medical, legal or regulatory terminology for clinical trial documents). Providers working to ISO 17100 standards also require a second linguist to review every translation, adding an essential quality-assurance layer that self-certification or untrained translators cannot provide.